IMMUCELL CORP /DE/ (ICCC) › Capital ExpendituresIMMUCELL CORP /DE/ (ICCC) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2009: $459.5K2010: $116.5K2011: $243.7K2012: $275.4K2013: $597.7K2014: $1.54M2015: $2.72M2016: $3.59M2017: $17.76M2018: $2.03M2019: $1.39M2020: $4.07M2021: $2.61M2022: $3.98M2023: $1.89M2024: $465.7K2025: $1.25M$1.25M2009Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$1.25M+168.5%2024$465.7K-75.4%2023$1.89M-52.4%2022$3.98M+52.4%2021$2.61M-35.9%2020$4.07M+192.7%2019$1.39M-31.5%2018$2.03M-88.6%2017$17.76M+395.2%2016$3.59M+31.9%2015$2.72M+77.1%2014$1.54M+156.9%2013$597.7K+117.0%2012$275.4K+13.0%2011$243.7K+109.1%2010$116.5K-74.6%2009$459.5K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share